133 related articles for article (PubMed ID: 20373322)
1. Efflux pump inhibitors: a strategy to combat P-glycoprotein and the NorA multidrug resistance pump.
Zhang L; Ma S
ChemMedChem; 2010 Jun; 5(6):811-22. PubMed ID: 20373322
[TBL] [Abstract][Full Text] [Related]
2. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
[TBL] [Abstract][Full Text] [Related]
3. Citral derived amides as potent bacterial NorA efflux pump inhibitors.
Thota N; Koul S; Reddy MV; Sangwan PL; Khan IA; Kumar A; Raja AF; Andotra SS; Qazi GN
Bioorg Med Chem; 2008 Jul; 16(13):6535-43. PubMed ID: 18524600
[TBL] [Abstract][Full Text] [Related]
4. Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles.
Holler JG; Slotved HC; Mølgaard P; Olsen CE; Christensen SB
Bioorg Med Chem; 2012 Jul; 20(14):4514-21. PubMed ID: 22682300
[TBL] [Abstract][Full Text] [Related]
5. Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
Sangwan PL; Koul JL; Koul S; Reddy MV; Thota N; Khan IA; Kumar A; Kalia NP; Qazi GN
Bioorg Med Chem; 2008 Nov; 16(22):9847-57. PubMed ID: 18848780
[TBL] [Abstract][Full Text] [Related]
6. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.
Sabatini S; Gosetto F; Iraci N; Barreca ML; Massari S; Sancineto L; Manfroni G; Tabarrini O; Dimovska M; Kaatz GW; Cecchetti V
J Med Chem; 2013 Jun; 56(12):4975-89. PubMed ID: 23710549
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors.
Samosorn S; Bremner JB; Ball A; Lewis K
Bioorg Med Chem; 2006 Feb; 14(3):857-65. PubMed ID: 16203150
[TBL] [Abstract][Full Text] [Related]
8. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
Kumar A; Khan IA; Koul S; Koul JL; Taneja SC; Ali I; Ali F; Sharma S; Mirza ZM; Kumar M; Sangwan PL; Gupta P; Thota N; Qazi GN
J Antimicrob Chemother; 2008 Jun; 61(6):1270-6. PubMed ID: 18334493
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
[TBL] [Abstract][Full Text] [Related]
10. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance].
Doléans-Jordheim A; Michalet S; Bergeron E; Boisset S; Souard F; Dumontet C; Dijoux-Franca MG; Freney J
Ann Biol Clin (Paris); 2008; 66(5):499-508. PubMed ID: 18957338
[TBL] [Abstract][Full Text] [Related]
11. Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors.
Sabatini S; Gosetto F; Serritella S; Manfroni G; Tabarrini O; Iraci N; Brincat JP; Carosati E; Villarini M; Kaatz GW; Cecchetti V
J Med Chem; 2012 Apr; 55(7):3568-72. PubMed ID: 22432682
[TBL] [Abstract][Full Text] [Related]
12. Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
Nargotra A; Sharma S; Koul JL; Sangwan PL; Khan IA; Kumar A; Taneja SC; Koul S
Eur J Med Chem; 2009 Oct; 44(10):4128-35. PubMed ID: 19523722
[TBL] [Abstract][Full Text] [Related]
13. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
Rieg S; Huth A; Kalbacher H; Kern WV
Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
Kaye SB
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
[TBL] [Abstract][Full Text] [Related]
15. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor.
Stermitz FR; Lorenz P; Tawara JN; Zenewicz LA; Lewis K
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1433-7. PubMed ID: 10677479
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
Fournier Dit Chabert J; Marquez B; Neville L; Joucla L; Broussous S; Bouhours P; David E; Pellet-Rostaing S; Marquet B; Moreau N; Lemaire M
Bioorg Med Chem; 2007 Jul; 15(13):4482-97. PubMed ID: 17498961
[TBL] [Abstract][Full Text] [Related]
17. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
Hasdemir U
Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
[TBL] [Abstract][Full Text] [Related]
18. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
Arora A; Seth K; Kalra N; Shukla Y
Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance in cancer: its mechanism and its modulation.
Pauwels EK; Erba P; Mariani G; Gomes CM
Drug News Perspect; 2007; 20(6):371-7. PubMed ID: 17925891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
